<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>According to the current guidelines, patients with ischaemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (ICM) or non-ischaemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (NICM) at risk for <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> should undergo implantation of an implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Although <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> effectively terminate <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo>, the arrhythmogenic substrate remains unchanged or may progress over time, resulting in recurrent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks </plain></SENT>
<SENT sid="2" pm="."><plain>Defibrillator shocks increase mortality and worsen quality of life </plain></SENT>
<SENT sid="3" pm="."><plain>Evidence from two prospective randomized trials on outcome in patients with <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischaemic heart disease</z:e> undergoing catheter ablation for <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) suggests that ablation prevents recurrence of VT and decreases the number of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> shocks </plain></SENT>
<SENT sid="4" pm="."><plain>This review will highlight the recent progress made in the ablative treatment of VT in patients with ICM and NICM </plain></SENT>
</text></document>